202 related articles for article (PubMed ID: 21912327)
21. Considerations in analyzing single-trough concentrations using mixed-effects modeling.
Booth BP; Gobburu JV
J Clin Pharmacol; 2003 Dec; 43(12):1307-15. PubMed ID: 14615466
[TBL] [Abstract][Full Text] [Related]
22. Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.
Bach T; An G
J Pharmacokinet Pharmacodyn; 2021 Aug; 48(4):581-595. PubMed ID: 33884580
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
Terziivanov D; Atanasova I; Dimitrova V
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352
[TBL] [Abstract][Full Text] [Related]
24. Fuzzy least squares for identification of individual pharmacokinetic parameters.
Seng KY; Nestorov I; Vicini P
IEEE Trans Biomed Eng; 2009 Dec; 56(12):2796-805. PubMed ID: 19695981
[TBL] [Abstract][Full Text] [Related]
25. Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data.
Yang S; Roger J
Pharm Stat; 2010; 9(4):313-30. PubMed ID: 20043295
[TBL] [Abstract][Full Text] [Related]
26. [The use of the expectation-maximization (EM) algorithm for maximum likelihood estimation of gametic frequencies of multilocus polymorphic codominant systems based on sampled population data].
Sergeev AS; Arapova RK
Genetika; 2002 Mar; 38(3):407-18. PubMed ID: 11963570
[TBL] [Abstract][Full Text] [Related]
27. Maximum-entropy expectation-maximization algorithm for image reconstruction and sensor field estimation.
Hong H; Schonfeld D
IEEE Trans Image Process; 2008 Jun; 17(6):897-907. PubMed ID: 18482885
[TBL] [Abstract][Full Text] [Related]
28. Object dependency of resolution in reconstruction algorithms with interiteration filtering applied to PET data.
Mustafovic S; Thielemans K
IEEE Trans Med Imaging; 2004 Apr; 23(4):433-46. PubMed ID: 15084069
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
30. Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.
Farenc C; Fabreguette JR; Bressolle F
Comput Biomed Res; 2000 Oct; 33(5):315-29. PubMed ID: 11017724
[TBL] [Abstract][Full Text] [Related]
31. Bias in error estimation when using cross-validation for model selection.
Varma S; Simon R
BMC Bioinformatics; 2006 Feb; 7():91. PubMed ID: 16504092
[TBL] [Abstract][Full Text] [Related]
32. The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.
Kjellsson MC; Jönsson S; Karlsson MO
AAPS J; 2004 Aug; 6(3):e19. PubMed ID: 15760104
[TBL] [Abstract][Full Text] [Related]
33. Nonlinearity detection: advantages of nonlinear mixed-effects modeling.
Jonsson EN; Wade JR; Karlsson MO
AAPS PharmSci; 2000; 2(3):E32. PubMed ID: 11741248
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.
Johansson ÅM; Ueckert S; Plan EL; Hooker AC; Karlsson MO
J Pharmacokinet Pharmacodyn; 2014 Jun; 41(3):223-38. PubMed ID: 24801864
[TBL] [Abstract][Full Text] [Related]
35. A pragmatic approach to the design of population pharmacokinetic studies.
Roy A; Ette EI
AAPS J; 2005 Oct; 7(2):E408-20. PubMed ID: 16353920
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance.
Zhang L; Beal SL; Sheiner LB
J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):387-404. PubMed ID: 15000421
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.
Baverel PG; Savic RM; Wilkins JJ; Karlsson MO
J Pharmacokinet Pharmacodyn; 2009 Aug; 36(4):297-315. PubMed ID: 19572188
[TBL] [Abstract][Full Text] [Related]
38. Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.
Plan EL; Maloney A; Mentré F; Karlsson MO; Bertrand J
AAPS J; 2012 Sep; 14(3):420-32. PubMed ID: 22528503
[TBL] [Abstract][Full Text] [Related]
39. Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.
Hooker AC; Staatz CE; Karlsson MO
Pharm Res; 2007 Dec; 24(12):2187-97. PubMed ID: 17612795
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of population D-optimal designs via pharmacokinetic simulations.
Hooker AC; Foracchia M; Dodds MG; Vicini P
Ann Biomed Eng; 2003 Jan; 31(1):98-111. PubMed ID: 12572660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
